Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guiping Ren

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Journal of Materials Chemistry. B|July 21, 2025
Rare earth-based two-dimensional materials for biomedical researchZhijing Zhu, Guiping Ren, Shiyi Xiong, et al.
Immunology Letters|March 12, 2014
Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapyFuliang Bai, Zeshan Niu, Hui Tian, et al.
Journal of Diabetes and Its Complications|December 3, 2014
Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetesPengfei Xu, Xianlong Ye, Yingjie Zhang, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|April 8, 2014
[Preparation and penetrating effect of the polyarginine-enhanced green fluorescence protein fusion protein]Nan Zhang, Yin Bai, Jingzhuang Zhao, et al.
Frontiers in Microbiology|March 20, 2019
Natural Extracellular Electron Transfer Between Semiconducting Minerals and Electroactive Bacterial Communities Occurred on the Rock VarnishGuiping Ren, Yingchun Yan, Yong Nie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 10, 2020
FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stressKai Kang, Pengfei Xu, Mengxia Wang, et al.
Molecular Immunology|October 5, 2013
Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritisJianying Qi, Xianlong Ye, Guiping Ren, et al.
Current Pharmaceutical Biotechnology|January 18, 2014
Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice modelFangming Kan, Guiping Ren, Mo Guo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 21, 2020
Fibroblast growth factor 21: a novel long-acting hypoglycemic drug for canine diabetesXinghao Jiang, Shijie Liu, Yaoqun Wang, et al.
Journal of Biotechnology|April 26, 2016
Pilot-scale production and characterization of PEGylated human FGF-21 analogXianlong Ye, Jianying Qi, Dan Yu, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Journal of Materials Chemistry. B|July 21, 2025
Rare earth-based two-dimensional materials for biomedical researchZhijing Zhu, Guiping Ren, Shiyi Xiong, et al.
Immunology Letters|March 12, 2014
Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapyFuliang Bai, Zeshan Niu, Hui Tian, et al.
Journal of Diabetes and Its Complications|December 3, 2014
Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetesPengfei Xu, Xianlong Ye, Yingjie Zhang, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|April 8, 2014
[Preparation and penetrating effect of the polyarginine-enhanced green fluorescence protein fusion protein]Nan Zhang, Yin Bai, Jingzhuang Zhao, et al.
Frontiers in Microbiology|March 20, 2019
Natural Extracellular Electron Transfer Between Semiconducting Minerals and Electroactive Bacterial Communities Occurred on the Rock VarnishGuiping Ren, Yingchun Yan, Yong Nie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 10, 2020
FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stressKai Kang, Pengfei Xu, Mengxia Wang, et al.
Molecular Immunology|October 5, 2013
Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritisJianying Qi, Xianlong Ye, Guiping Ren, et al.
Current Pharmaceutical Biotechnology|January 18, 2014
Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice modelFangming Kan, Guiping Ren, Mo Guo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 21, 2020
Fibroblast growth factor 21: a novel long-acting hypoglycemic drug for canine diabetesXinghao Jiang, Shijie Liu, Yaoqun Wang, et al.
Journal of Biotechnology|April 26, 2016
Pilot-scale production and characterization of PEGylated human FGF-21 analogXianlong Ye, Jianying Qi, Dan Yu, et al.
Pageof 11